These outcomes, together with a prior report showing that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 guidance the concept of focusing on ACKR3 as a unique strategy to modulate the opioid program, which could open up new therapeutic avenues for opioid-associated disorders. A new review shows https://terryv946pgp0.weblogco.com/profile